Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma

Background: The expression of INMT (indolethylamine N-methyltransferase) has been reported to be downregulated in non-small-cell lung cancer (NSCLC). However, the role of INMT in NSCLC remains elusive. We aim to investigate the underlying mechanisms and clinical value of INMT in NSCLC, especially in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xincheng, Zou, Bing, Wang, Jian, Wu, Lihong, Tan, Qiang, Ji, Chunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686007/
https://www.ncbi.nlm.nih.gov/pubmed/36437916
http://dx.doi.org/10.3389/fgene.2022.946848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686007/
https://www.ncbi.nlm.nih.gov/pubmed/36437916
http://dx.doi.org/10.3389/fgene.2022.946848

Ejemplares similares